Neuro-Oncology News

Glioblastoma continues to be one of the most aggressive malignancies, with no profound breakthroughs despite incremental improvements. Patients and physicians are desperate for new treatments, and immunotherapy rapidly should become a standard of care if any positive data develop.

Glioblastoma is the most common primary brain neoplasm, accounting for approximately 15% of all intracranial tumors.

Cancer mortality in the United States decreased by more than 20% from 1980 to 2014, according to a study conducted by researchers from University of Washington and published in JAMA.

The investigational hallucinogenic drug psilocybin reduced clinician- and patient-reported depression, anxiety and mortality-associated anxiety among adults with cancer, according to results of a small double blind study.

Fewer than half of childhood cancer survivors receive recommended long-term follow-up care, according to findings of a study led by researchers at Roswell Park Cancer Institute.

The implementation of a simple technology to collect and store patient-reported outcomes could improve patients’ quality of life and outcomes and enhance patient–provider communication, according to Ethan Basch, MD, MSc, director of UNC Lineberger Cancer Outcomes Research program.

The number of cancer survivors in the United States is projected to swell from 15.5 million in 2016 to more than 26 million by 2040.

Click here to read the Cover Story, "‘Silver tsunami’ requires ‘all-hands-on-deck’ approach to cancer survivorship"

The American Academy for Cancer Research released the first set of cancer genomic data from Project GENIE, a multiphase, international data-sharing effort.

A steady decline in smoking and advances in early detection and treatment have contributed to a 25% reduction in cancer death rates in the United States since 1991, according to Cancer Statistics 2017, the American Cancer Society’s comprehensive annual report on cancer incidence, mortality and survival.